Immune system B-cells can help predict HER2-positive breast cancer treatment response

byUNC Lineberger Comprehensive Cancer CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Ce

Updated on: January 02,2024

Immune system B-cells can help predict HER2-positive breast cancer treatment response

byUNC Lineberger Comprehensive Cancer CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Ce

Updated on:January 02,2024

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

by Ludwig Institute for Cancer ResearchRalph Weichselbaum is the co-director of the Ludwig Center at Chicago. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research study has uncovered a key mech

Updated on: March 12,2024

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

by Ludwig Institute for Cancer ResearchRalph Weichselbaum is the co-director of the Ludwig Center at Chicago. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research study has uncovered a key mech

Updated on:March 12,2024

Digital rectal examination is not useful to early detect prostate cancers, says new research

by European Association of UrologyCredit: Unsplash/CC0 Public DomainA common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have

Updated on: January 30,2024

Digital rectal examination is not useful to early detect prostate cancers, says new research

by European Association of UrologyCredit: Unsplash/CC0 Public DomainA common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have

Updated on:January 30,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on: May 31,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on:May 31,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on: January 23,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on:January 23,2024

Research reveals promising new combination treatment for bladder cancer patients

by Memorial Sloan Kettering Cancer CenterCredit: OpenStax College, CC BY 3.0, via Wikimedia CommonsResearchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment

Updated on: February 03,2024

Research reveals promising new combination treatment for bladder cancer patients

by Memorial Sloan Kettering Cancer CenterCredit: OpenStax College, CC BY 3.0, via Wikimedia CommonsResearchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment

Updated on:February 03,2024

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn a recently published editorial in the journalGenes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hosp

Updated on: January 16,2024

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn a recently published editorial in the journalGenes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hosp

Updated on:January 16,2024

New tumor-selective light treatment could kill breast cancer cells with greater accuracy and improve tumor control

byNational University of SingaporeGraphical abstract. Credit:ACS Nano(2023). DOI: 10.1021/acsnano.3c01916Breast cancer is the most common cancer affecting women in Singapore. Treatme

Updated on: January 13,2024

New tumor-selective light treatment could kill breast cancer cells with greater accuracy and improve tumor control

byNational University of SingaporeGraphical abstract. Credit:ACS Nano(2023). DOI: 10.1021/acsnano.3c01916Breast cancer is the most common cancer affecting women in Singapore. Treatme

Updated on:January 13,2024

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on: January 22,2024

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on:January 22,2024

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on: March 20,2024

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on:March 20,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Updated on: February 18,2024

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Updated on:February 18,2024